Combined substituted oxazolidinone therapy

• 收藏
• 分享

专利权人:

Bayer Intellectual Property GmbH

发明人:

PERZBORN, Elisabeth

申请号：

ES07819133

公开号：

ES2644489T3

申请日:

2007.10.19

申请国别(地区):

ES

年份:

2017

代理人:

摘要：

The present invention relates to combinations of A) oxazolidinones of the formula (I) with B) acetylsalicylic acid (aspirin) and C) an ADP receptor antagonist, in particular P2Y12 purinoreceptor blocker, to a process for producing these combinations and to the use thereof as medicaments, in particular for the prophylaxis and/or treatment of thromboembolic disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/